JUBLPHARMA1,026.00

Jubilant Pharmova Ltd.

· Pharma & Health
₹ CrorePeersGLANDPPLPHARMAKIMSINDGNONESOURCEGRANULESPFIZERPOLYMEDMcap ₹16,211 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment2,157.82,132.33,509.63,509.6
+ Capital Work-in-Progress1,252.32,714.72,961.52,961.5
+ Goodwill2,463.92,541.02,826.12,826.1
+ Other Intangibles192.5181.4197.7197.7
+ Intangibles under Development850.8915.31,078.91,078.9
+ Investments (Equity Method)7.87.50.80.8
+ Non-current Investments34.436.060.660.6
+ Long-term Loans0.30.30.30.3
+ Other Non-current Financial Assets19.826.630.430.4
Non-current Financial Assets54.562.991.391.3
+ Deferred Tax Assets232.7257.4257.1257.1
+ Other Non-current Assets460.1366.7490.4490.4
Total Non-current Assets7,672.49,179.211,413.411,413.4
Current Assets
+ Inventories1,289.61,129.21,231.51,231.5
+ Trade Receivables915.9891.51,069.61,069.6
+ Cash & Cash Equivalents956.41,088.31,267.11,267.1
+ Other Bank Balances0.40.50.50.5
+ Short-term Loans0.81.11.91.9
+ Other Current Financial Assets247.4160.5218.9218.9
Current Financial Assets2,120.92,141.92,558.02,558.0
+ Other Current Assets205.0220.6249.0249.0
Total Current Assets3,632.23,509.74,109.34,109.3
Total Assets11,548.512,756.415,522.715,522.7
Equity
+ Equity Share Capital15.815.815.815.8
+ Other Equity / Reserves5,418.16,239.17,077.07,077.0
Equity — Owners of Parent5,433.96,254.97,092.87,092.8
+ Minority Interest-12.8-16.32.82.8
Total Equity5,421.16,238.67,095.67,095.6
Liabilities
+ Borrowings — Non-current3,167.12,150.32,971.72,971.7
+ Other Non-current Financial Liab216.6774.11,134.31,134.3
Non-current Financial Liabilities3,383.72,924.44,106.04,106.0
+ Provisions — Non-current100.1119.1159.5159.5
+ Deferred Tax Liabilities210.8172.2250.7250.7
+ Other Non-current Liabilities543.81,137.51,372.01,372.0
Non-current Liabilities4,238.44,353.25,888.25,888.2
+ Borrowings — Current247.0286.6247.8247.8
+ Trade Payables856.31,004.81,234.11,234.1
+ Other Current Financial Liab519.1574.3602.3602.3
Current Financial Liabilities1,622.41,865.72,084.22,084.2
+ Provisions — Current66.478.494.394.3
+ Current Tax Liabilities37.018.420.120.1
+ Other Current Liabilities163.2202.1340.3340.3
Current Liabilities1,889.02,164.62,538.92,538.9
Total Liabilities6,127.46,517.88,427.18,427.1
Total Equity & Liabilities11,548.512,756.415,522.715,522.7
Assets — additional as-filed lines
+ Non-current Assets Held for Sale243.967.5
+ Current Tax Assets16.718.070.870.8
Trade Payables — MSME split
+ Dues to Micro & Small — Current34.323.023.0
+ Dues to Other Creditors — Current970.51,211.11,211.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.